Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryRevolving Doors: Mayer Brown hires Kirkland lev fin partner as Garrigues and Cuatrecasas make moves in ChileLaw firmsWill Lewallen22 Apr 2026Competition for talent heats up as Wachtell restructuring head lands at KirklandLaw firmsTom Cox21 Apr 2026Revolving Doors: Weil hires Kirkland secondaries partner as Orrick targets Cadwalader againLaw firmsKate Peacock14 Apr 2026Vinson & Elkins bets on London – New York – Houston ‘triangle’ for growthLaw firmsKate Peacock23 Apr 2026How CMS M&A partner David Roberts became the restaurant expert on both sides of the tableLaw firmsKate Peacock20 Apr 2026‘We’ve got the building blocks in place to grow’ – Harbottle closes in on £60mLaw firmsTom Cox17 Apr 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025